Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PARP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TYROBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FEZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929372 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RSRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAPPC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCOLN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYZL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBFA2T2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on